Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

IL7 increases targeted lipid nanoparticle–mediated mRNA expression in T cells in vitro and in vivo by enhancing T cell protein translation
Caitlin M. Tilsed, Barzan A. Sadiq, Tyler E. Papp, et al.
Proceedings of the National Academy of Sciences (2024) Vol. 121, Iss. 13
Open Access | Times Cited: 16

Showing 16 citing articles:

An Overview of Nanoparticle-Based Delivery Platforms for mRNA Vaccines for Treating Cancer
Lin Yang, Xuehua Chen, Ke Wang, et al.
Vaccines (2024) Vol. 12, Iss. 7, pp. 727-727
Open Access | Times Cited: 14
Tailoring Highly Branched Poly(β-amino ester)s for Efficient and Organ-Selective mRNA Delivery
Haiyang Yong, Lixin Lin, Zhili Li, et al.
Nano Letters (2024) Vol. 24, Iss. 30, pp. 9368-9376
Closed Access | Times Cited: 8
Engineering CAR‐T Therapeutics for Enhanced Solid Tumor Targeting
Danqing Zhu, Wonjoon Kim, Hyunjin Lee, et al.
Advanced Materials (2025)
Closed Access | Times Cited: 1
UTR-Insight: integrating deep learning for efficient 5′ UTR discovery and design
Saichao Pan, Hanyu Wang, Hang Zhang, et al.
BMC Genomics (2025) Vol. 26, Iss. 1
Open Access
Non-viral vectors for chimeric antigen receptor immunotherapy
Sandy Tretbar, Joel G. Rurik, Even H Rustad, et al.
Nature Reviews Methods Primers (2024) Vol. 4, Iss. 1
Closed Access | Times Cited: 4
IL-7 Immunotherapies: Current Applications and Engineering Opportunities
Emily Ariail, Benjamin Biggs, Rowan O’Flanagan, et al.
Immunological Investigations (2025), pp. 1-19
Closed Access
Scarless circular mRNA-based CAR-T cell therapy elicits superior anti-tumor efficacy
Qinchao Hu, Hui Zhao, Kaicheng Zhou, et al.
bioRxiv (Cold Spring Harbor Laboratory) (2024)
Open Access | Times Cited: 3
Current landscape of mRNA technologies and delivery systems for new modality therapeutics
Ruei‐Min Lu, Hsiang-En Hsu, Ser John Lynon P Perez, et al.
Journal of Biomedical Science (2024) Vol. 31, Iss. 1
Open Access | Times Cited: 3
Recent advances in mRNA-based cancer vaccines encoding immunostimulants and their delivery strategies
Seyyed Majid Eslami, Xiuling Lü
Journal of Controlled Release (2024) Vol. 376, pp. 413-428
Closed Access | Times Cited: 1
Design and development of mRNA and self-amplifying mRNA vaccine nanoformulations
Yadollah Omidi, Mohammad M. Pourseif, Rais A. Ansari, et al.
Nanomedicine (2024), pp. 1-27
Closed Access | Times Cited: 1
IL-7 promotes mRNA vaccine-induced long-term immunity
Lingli Wang, Jiawu Wan, Wenna He, et al.
Journal of Nanobiotechnology (2024) Vol. 22, Iss. 1
Open Access | Times Cited: 1
Bispecific antibody targeting of lipid nanoparticles
Angelo Amabile, Michael Phelan, Zhe Yu, et al.
bioRxiv (Cold Spring Harbor Laboratory) (2024)
Open Access | Times Cited: 1
An Overview of Nanoparticle-Based Delivery Platforms for Vaccines
Lin Yang, Xuehua Chen, Ke Wang, et al.
(2024)
Open Access
Determining potential immunomodulatory drug efficacy in sepsis using ELISpot
Andrew H. Walton, MB Mazer, KE Remy, et al.
(2024)
Closed Access
MARCH8 Mediates K27-Linked Polyubiquitination of IL-7 Receptor α to Negatively Regulate IL-7–Triggered T Cell Homeostasis
Deng Gao, Xuemei Yi, Lu Feng, et al.
The Journal of Immunology (2024) Vol. 213, Iss. 10, pp. 1467-1478
Closed Access
In vivo engineering chimeric antigen receptor immune cells with emerging nanotechnologies
Hui Ren, Yuzhi Jin, Huanhuan Huang, et al.
Nano Today (2024) Vol. 59, pp. 102517-102517
Closed Access
Page 1

Scroll to top